Biomet reported a net sales increase of 3 percent worldwide to approximately $740 million, while sales in the U.S. alone increased 7 percent. The device manufacturer saw growth in knee sales (4 percent worldwide), hip sales (3 percent worldwide), sports medicine sales (19 percent worldwide) and extremity sales (20 percent worldwide).
Other device makers’ shares grew after this report was released. Shares for Zimmer Holdings, Wright Medical Group and Smith & Nephew were up $2.44, $0.36 and $0.30, respectively.
Related Articles on Orthopedic Devices:
Precision Spine Acquires Spinal USA, Precision Medical for $72M
Integra LifeSciences Launches Integra Toe Joint Fusion System
Minimally Invasive TLIF Saves $6k vs. Open Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.